Saudi Pharmaceutical Industries & Medical Appliances Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Saudi Pharmaceutical Industries & Medical Appliances with three other
pharmaceutical manufacturers in Middle East:
Dar Al Dawa Development & Investment
sales of 60.88 million Jordanian Dinars [US$85.74 million]
of which 80%
Glaxo Smith Kline
(1.17 billion Egyptian Pounds [US$64.98 million]
of which 93%
was Medical Sector), and
Egypt International Pharmaceuticals
based in Egypt
(1.97 billion Egyptian Pounds [US$109.76 million]
of which 100%
Saudi Pharmaceutical Industries & Medical Appliances reported sales of 1.84 billion Saudi Riyals (US$490.99 million)
December of 2016.
increase of 8.0%
versus 2015, when the company's sales were 1.71 billion Saudi Riyals.
Sales at Saudi Pharmaceutical Industries & Medical Appliances have increased during each of the previous five years
(and since 2011, sales have increased a total of 63%).
Sales of Investments saw an increase
that was more than double the company's growth rate: sales were up
135.2% in 2016, from
115.14 million Saudi Riyals to 270.76 million Saudi Riyals.